Shares outstanding · 2018–2025

Bridgebio Pharma shares outstanding

194M+1.9% · FY2025

Bridgebio Pharma (BBIO) reported 194M in shares outstanding for fiscal 2025, +1.9% year on year.

92.1M2018124M2019123M2020147M2021151M2022175M2023190M2024194M2025
Bridgebio Pharma — Shares outstanding, 2018–2025
Fiscal yearShares outstandingChangeFiling
FY20252026-02-12194M+1.9%Open →
FY20242025-02-13190M+8.6%Open →
FY20232023-12-31175M+16.2%Open →
FY20222022-12-31151M+2.2%Open →
FY20212021-12-31147M+19.9%Open →
FY20202020-12-31123M−0.7%Open →
FY20192019-12-31124M+34.3%Open →
FY20182018-12-3192.1M—Open →

Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +11.2%

Shares outstanding at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Bridgebio Pharma shares outstanding |url=https://companiesranked.com/en/company/bridgebio-pharma/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Bridgebio Pharma shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/bridgebio-pharma/shares-outstanding

BibTeX

@misc{companiesranked-en-company-bridgebio-pharma-shares-outstanding-2026,
  author       = {{CompaniesRanked}},
  title        = {{Bridgebio Pharma shares outstanding}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/bridgebio-pharma/shares-outstanding}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001743881-26-000009 · February 24, 2026

{{cite web |title=Bridgebio Pharma shares outstanding — 10-K (0001743881-26-000009) |url=https://www.sec.gov/Archives/edgar/data/1743881/000174388126000009/bbio-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Bridgebio Pharma overview